After completing this activity, participants should be better able to: Apply evidence-based criteria and tumor-specific needs to determine selection and sequence of multidisciplinary specialists in the management of cutaneous squamous cell carcinoma Incorporate current evidence and clinical factors to individualize the selection and sequencing of immunotherapy for CSCC in coordination with surgery and radiation, particularly in the perioperative setting Discuss risk stratification frameworks to recognize high-risk clinical and pathologic features and guide management approaches for locally advanced, recurrent, nodal, and metastatic cSCC
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 35 Nutmeg Drive
Pricing
100% of listed courses are free
20 of 20 courses listed here are free.
Collected from the provider’s public pages · source
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedSep 11, 2026
-
Last day to claim creditSep 12, 2027 11 months left
-
Talem Health, LLC Adjuvant Therapy in Recurrent High-Risk Cutaneous Squamous Cell Carcinoma: Advancing Multidisciplinary Decision-Making
-
Talem Health, LLC Coordinating Immunotherapy and Optimizing Patient Preparation Across the Care Team: Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma
-
Talem Health, LLC Integrating Immunotherapy Into Guideline-Based Care: Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma
-
Medscape, LLC Who Is On Your Speed Dial? A Multidisciplinary Approach to Cutaneous Squamous Cell Carcinoma
-
Answers in CME Inc. (AiCME) From Surgery to Systemic Therapy: A Collaborative Discussion on CSCC Neoadjuvant and Adjuvant Immunotherapy
-
CME Outfitters, LLC Multidisciplinary Tumor Board Practice to Enhance Treatment Planning, Shared Decision-Making, and AE Management in Locally Advanced HNSCC
